Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PTC THERAPEUTICS, INC. Director's Dealing 2014

Jun 11, 2014

31046_dirs_2014-06-11_71787cdf-c8bf-4150-8d34-b9358ba3161e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2014-06-10

Reporting Person: Renaud Ronald C JR (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-06-10 Stock Option (right to buy) $25.38 A 20000 Acquired 2024-06-09 Common Stock (20000) Direct

Footnotes

F1: This option award vests over three years in equal increments upon each anniversary of the date of grant. Granted upon the election of the Reporting Person as non-employee director of the Issuer.